Summary
The predisposition of patients with lobular carcinoma in situ (LCIS) to develop invasive breast cancer (IBC) is well known. However, relatively little is known about the biologic characteristics, which may be involved in the development and progression of LCIS. This study evaluated 59 cases of LCIS (29 pure, 30 with synchronous IBC) for five biomarkers known to be important in IBC (ER, PgR, c-erbB-2, p53 and Ki-67 proliferation rate) by immunohistochemistry. A comprehensive analysis of loss-of-heterozygosity (LOH) was performed in 12 cases (10 pure, 2 with synchronous IBC) at 15 genetic loci on 9 chromosomes. LCIS demonstrated a low grade/favorable biophenotype that was not significantly different in cases with and without synchronous IBC (ER 98%, PgR 84%, c-erbB-24%, p53 19% and proliferation rate 2%). LOH was present in 80% of pure LCIS and the highest rates of LOH were at loci on 9p (30%), 16q (63%), 17p (33%) and 17q (50%). The clustering of LOH at these four foci suggests that inactivated tumor suppressor genes in these regions may be particularly important. LOH was present in both cases of LCIS with synchronous IBC and the LOH phenotype was shared by LCIS and IBC. Our findings suggest that five known prognostic factors in IBC do not have prognostic utility in LCIS. Multiple genetic mechanisms may be involved in the development of LCIS.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
FW Foote FW Stewart (1994) ArticleTitleLobular carcinoma in situ: a rare form of mammary cancer Am J Pathol 17 491–495
D Page W Dupont L Rogers M Rados (1985) ArticleTitleAtypical hyperplastic lesions of the female breast Cancer 55 2698–2708 Occurrence Handle2986821 Occurrence Handle1:STN:280:DyaL2M3gtFemtg%3D%3D
JL Connolly SJ Schnitt SJ London W Dupont GA Colditz DL Page (1992) ArticleTitleBoth atypical lobular hyperplasia (ALH) and atypical ductal hyperplasia (ADH) predict for bilateral breast cancer risk Lab Invest 66 13A
LM Marshall DJ Hunter JL Connolly SJ Schnitt C Byrne SJ London GA Colditz (1997) ArticleTitleRisk of breast cancer associated with atypical hyperplasia of lobular and ductal types Cancer Epidemiol Biomarkers Prev 6 IssueID5 297–301 Occurrence Handle9149887 Occurrence Handle1:STN:280:DyaK2s3psVSjsA%3D%3D
CD Haagensen N Lane R Lattes C Bodian (1978) ArticleTitleLobular Neoplasia (so-called lobular carcinoma in situ) of the breast Cancer 42 737–769 Occurrence Handle209887 Occurrence Handle1:STN:280:DyaE1c3js12ltQ%3D%3D
E Frykberg F Santiago W Betsill P O’Brien (1987) ArticleTitleLobular carcinoma in situ of the breast Surg Gynecol Obstet 164 285–301 Occurrence Handle3547723 Occurrence Handle1:STN:280:DyaL2s7kvFGjsA%3D%3D
F Gump (1993) ArticleTitleLobular carcinoma in situ (LCIS): pathology and treatment J Cell Biochem 17 53–58
D Page W Dupont L Rogers M Landenberger (1982) ArticleTitleIntraductal carcinoma of the breast: follow-up after biopsy only Cancer 49 751–758 Occurrence Handle6275978 Occurrence Handle1:STN:280:DyaL387hsV2ltg%3D%3D
PP Rosen C Kosloff PH Lieberman F Adair DW Braun SuffixJr (1978) ArticleTitleLobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years Am J Surg Pathol 2 IssueID3 225–251 Occurrence Handle210682 Occurrence Handle1:STN:280:DyaE1c3lsVGqug%3D%3D Occurrence Handle10.1097/00000478-197809000-00001
J Wheeler H Enterline J Roseman J Tomasulo C McIlvaine W Fitts J Kirscenbaum (1974) ArticleTitleLobular carcinoma of the breast. Long-term follow-up Cancer 34 554–563 Occurrence Handle4853024 Occurrence Handle1:STN:280:DyaE2czgsVWisA%3D%3D
JM Dixon TJ Anderson DL Page D Lee SW Duffy (1981) ArticleTitleInfiltrating lobular carcinoma of the breast Histopathology 6 IssueID2 149–161
R Nayar Z Zhengping MJ Merino SG Silverberg (1997) ArticleTitleLoss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction Hum Pathol 28 IssueID3 227–282
CBJ Vos AM Cleton-Jansen G Berx WJF Leeuw Particlede NT ter Haar F Roy Particlevan CJ Cornelisse JL Peterse MJ Vijer Particlevan de (1997) ArticleTitleE-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis Brit J Cancer 76 IssueID9 1131–1133 Occurrence Handle9365159 Occurrence Handle1:CAS:528:DyaK2sXntlOnsrw%3D
A Sapino A Frigerio JL Peterse R Arisio C Coluccia G Bussolati (2000) ArticleTitleMammographically detected in situ lobular carcinomas of the breast Virchows Arch 436 421–430 Occurrence Handle10881735 Occurrence Handle1:STN:280:DC%2BD3czjvVKntg%3D%3D
L Lieberman M Sama B Susnik PP Rosen LR La Trenta EA Morris AF Abramson DD Dershaw (1999) ArticleTitleLobular carcinoma in situ at percutaneous biopsy: surgical biopsy findings Am J Radiol 173 291–299
JF Simpson DL Page (1998) Lobular neoplasia: atypical lobular hyperplasia and lobular carcinoma in situ CW Elston IO Ellis (Eds) System Pathology: The Breast Churchill Livingstone Edinburgh 91–106
DC Allred GC Clark R Elledge SA Fuqua RW Brown GC Chamness CK Osborne WL McGuire (1993) ArticleTitleAssociation of p53 protein expression with tumor proliferation rate and clinical outcome in node-negative breast cancer J Natl Cancer Inst 35 200–206
DC Allred JM Harvey M Berardo GM Clark (1998) ArticleTitlePrognostic and predictive factors in breast cancer by immunohistochemical analysis Mod Pathol 11 IssueID2 155–168 Occurrence Handle9504686 Occurrence Handle1:STN:280:DyaK1c7mtlaitg%3D%3D
JM Harvey GM Clark CK Osborne DC Allred (1999) ArticleTitleEstrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer J Clin Oncol 17 IssueID5 1474–1481 Occurrence Handle10334533 Occurrence Handle1:STN:280:DyaK1M3msFOjsA%3D%3D
RM Elledge S Green R Pugh DC Allred GM Clark J Hill P Ravdin S Martino CK Osborne (2000) ArticleTitleEstrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study Int J Cancer 89 IssueID2 111–117 Occurrence Handle10754487 Occurrence Handle1:CAS:528:DC%2BD3cXislehsrw%3D
MJ Ellis A Coop B Singh L Mauriac A Llombert-Cussac F Janicke WR Miller DB Evans M Dugan C Brady E Quebe-Fehling M Borgs (2001) ArticleTitleLetrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial J Clin Oncol 19 IssueID18 3808–3816 Occurrence Handle11559718 Occurrence Handle1:CAS:528:DC%2BD3MXnsVKqsbo%3D
Mohsin SK, Clark GM, Havighurst T, Roanh LD, Qian Z, Love RR, Allred DC: Progesterone receptor by immunohistochemistry: a technical and clinical validation study in breast cancer. Mod Pathol 15(1): 43A (abstract # 168), 2002
DC Allred GM Clark AK Tandon R Molina DC Tormey CK Osborne KW Gilchrist EG Mansour M Abeloff L Eudey WL McGuire (1992) ArticleTitleHER-2/neu in node-negative breast cancer: prognostic significance of over expression influenced by the presence of in situ carcinoma J Clin Oncol 10 599–605 Occurrence Handle1548522 Occurrence Handle1:STN:280:DyaK387ptl2ksg%3D%3D
G Deng Y Lu G Zlotnikov A Thor H Smith (1996) ArticleTitleLoss of heterozygosity in normal tissue adjacent to breast carcinomas Science 274 2057–2059 Occurrence Handle8953032 Occurrence Handle1:CAS:528:DyaK2sXjtFSj
D Wright M Manos (1990) Sample preparation from paraffin embedded tissues M Innes D Gelfand J Snisky T White (Eds) PCR Protocols Academic Press San Diego 153–158
P O’Connell P Vladmimir S Fuqua C Osborne G Clark D Allred (1998) ArticleTitleAnalysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci JNCI 90 IssueID9 697–703 Occurrence Handle9586667
DL Page TE Kidd WD Dupont JF Simpson LW Rogers (1991) ArticleTitleLobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease Hum Pathol 22 1232–1239 Occurrence Handle1748429 Occurrence Handle1:STN:280:DyaK38%2FosVeitA%3D%3D
CA Bodian KH Perzin R Lattes (1996) ArticleTitleLobular neoplasia: long term risk of breast cancer and relation to other factors Cancer 78 1024–1034 Occurrence Handle8780540 Occurrence Handle1:STN:280:DyaK28znsVanuw%3D%3D
RW McDivitt RVP Hutter FW Foote FW. Stewart (1967) ArticleTitleIn situ lobular carcinoma JAMA 201 96–100
J Anderson (1974) ArticleTitleLobular carcinoma in situ: a long-term follow-up of 52 cases Acta Pahol Micorbiol Scand [A] Pathol 82 519–533
M Rudas R Neumayer M Gnant M Mittelbock R Jakesz A Reiner (1997) ArticleTitlep53 protein expression, cell proliferation and steroid hormone receptros in ductal and lobular in situ carcinomas of the breast Eur J Cancer 33 IssueID1 39–44 Occurrence Handle9071897 Occurrence Handle1:CAS:528:DyaK2sXit1yitL8%3D
P Querzoli G Albonico S Ferretti R Rinaldi D Beccati S Corcione M Indelli I Nenci (1998) ArticleTitleModulation of biomarkers in minimal breast carcinoma: a model for human breast carcinoma progression Cancer 83 IssueID1 89–97 Occurrence Handle9655297 Occurrence Handle1:STN:280:DyaK1czhvVSjsQ%3D%3D
BA Gusterson LG Machin WJ Gullick NM Gibbs TJ Powles C Elliott S Ashley P Monaghan S Harrison (1988) ArticleTitlec-erbB-2 expression in benign and malignant breast disease Brit J Cancer 58 453–457 Occurrence Handle2849975 Occurrence Handle1:STN:280:DyaL1M%2Fosl2mug%3D%3D
DD Giri SAC Dunda JF Nottingham JCE Underwood (1989) ArticleTitleOestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study Histopathology 15 575–584 Occurrence Handle2606454 Occurrence Handle1:STN:280:DyaK3c7gvFSmsQ%3D%3D
RF Lodato HCJ Maguire MI Greene dB Weiner VA Le Volsi (1990) ArticleTitleImmunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast Mod Pathol 3 449–454 Occurrence Handle2170971 Occurrence Handle1:STN:280:DyaK3M%2FhslCrsw%3D%3D
LP Pertschuk DS Kim K Nayer JG Feldman KB Eisenberg AC Carter ZT Rong WL Thelmo J Fleisher GL Greene (1990) ArticleTitleImmunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies Cancer 66 1663–1670 Occurrence Handle2208020 Occurrence Handle1:STN:280:DyaK3M%2FgtlyksQ%3D%3D
S Ramachandra L Machin S Ashley P Monaghan BA Gusterson (1990) ArticleTitleImmunohistochemical distribution of c-erbB-2 in in situ breast carcinoma: a detailed morphological analysis J Pathol 161 7–14 Occurrence Handle1973459 Occurrence Handle1:STN:280:DyaK3czhslOjtg%3D%3D
PL Porter R Garcia R Moe DJ Corwin AM Gown (1991) ArticleTitlec-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia Cancer 68 331–334 Occurrence Handle1676930 Occurrence Handle1:STN:280:DyaK3MzgtVChug%3D%3D
ME Bur MJ Zimarowski SJ Schnitt S Baker R Lew (1992) ArticleTitleEstrogen receptor immunohistochemistry in carcinoma in situ of the breast Cancer 69 1174–1181 Occurrence Handle1739917 Occurrence Handle1:STN:280:DyaK387lsVGlsQ%3D%3D Occurrence Handle10.1002/cncr.2820690518
L Pallis N Wilking B Cedermark LE Rutqvist L Skoog (1992) ArticleTitleReceptors for estrogen and progesterone in breast carcinoma in situ Anticancer Res 12 2113–2115 Occurrence Handle1295456 Occurrence Handle1:STN:280:DyaK3s7pvFaguw%3D%3D
H Schimmelpenning ET Eriksson L Pallis L Skoog B Cedermark GU. Auer (1992) ArticleTitleImmunohistochemical c-erbB-2 proto-oncogene expression and nuclear DNA content in human mammary carcinoma in situ Am J Clin Pathol 97 IssueIDsuppl 1 S48–S52 Occurrence Handle1374218 Occurrence Handle1:STN:280:DyaK383ks1Wksg%3D%3D
JE Somerville LA Clarke JD Biggart (1992) ArticleTitlec-erbB-2 overexpression and histological type of in situ and invasive breast carcinomas J Clin Pathol 45 16–20 Occurrence Handle1346789 Occurrence Handle1:STN:280:DyaK387ls1ejtw%3D%3D
W Domagala M Markiewski R Kubiak J Bartkowiak M Osborn (1993) ArticleTitleImmunohistochemical profile of invasive lobular carcinoma of the breast: predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive Virchows Archiv A Pathol Anat Histopathol 423 IssueID6 497–502 Occurrence Handle1:STN:280:DyaK2c7itVOisw%3D%3D
ER Fisher J Costantino B Fisher AS Palekar SM Paik CM Suarex N Wolmark (1996) ArticleTitlePathologic findings from the National Surgical Adjuvant Breast Progect (NSABP) protocol B-17 Cancer 78 1403–1416 Occurrence Handle8839545 Occurrence Handle1:STN:280:DyaK28vjs1Ohuw%3D%3D
KP Siziopikou JE Prioleau JR Harris SJ Schnitt (1996) ArticleTitleBcl-2 expression in the spectrum of preinvasive breast lesions Cancer 77 499–506 Occurrence Handle8630957 Occurrence Handle1:CAS:528:DyaK28Xht12jsLg%3D
D Allred M Berardo J Prosser P O’Connell (1997) Biologic and genetic features of in situ breast cancer M Silverstein (Eds) Ductal Carcinoma in situ of the Breast Williams and Wilkins Baltimore 37–49
SR Lakhani N Collins JP Sloane MR Stratton (1995) ArticleTitleLoss of heterozygosity in lobular carcinoma in situ of the breast J Clin Pathol: Mol Pathol 48 M74–M78 Occurrence Handle10.1136/mp.48.2.M74 Occurrence Handle1:STN:280:DC%2BC3crptFKitQ%3D%3D
DW Visscher TL Wallis JD Crissman (1996) ArticleTitleEvaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics Cancer 77 315–320 Occurrence Handle8625240 Occurrence Handle1:STN:280:DyaK283itleluw%3D%3D
WJF De Leeuw G Berx CBJ Vos JL Peterse MJ Vijver Particlevan de S Litvinov F Roy Particlevan CJ Cornelisse A Cleton-Jansen (1997) ArticleTitleSimultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ J Pathol 183 404–411 Occurrence Handle9496256 Occurrence Handle1:STN:280:DyaK1c7lslensw%3D%3D
G Berx A Cleton-Jansen F Nollet W Leeuw Particlede C Cornelisse F Roy Particlevan (1995) ArticleTitleE-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers EMBO J 14 6107–6115 Occurrence Handle8557030 Occurrence Handle1:CAS:528:DyaK28XjtVKjtQ%3D%3D
aM Davidoff B-JM Kerns JC Pence JR Marks JD Iglehart (1991) ArticleTitlep53 alterations in all stages of breast cancer J Surg Oncol 48 260–267 Occurrence Handle1745051 Occurrence Handle1:STN:280:DyaK38%2FnvFGjsQ%3D%3D
D Guttmann D Wood F Collins (1991) ArticleTitleIdentification of the neurofibromatosis type 1 gene product Proc Natl Acad Sci USA 88 9658–9662
L Friedman E Ostermeyer E Lynch C Szabo L Anderson P Dowd MK Lee SK Rowell J Boyd MC King (1994) ArticleTitleThe search for BRCA1 Cancer Res 54 6374–6382 Occurrence Handle7987831 Occurrence Handle1:CAS:528:DyaK2MXislalsr0%3D
J Nigro S Baker A Preisinger J Jessup R Hostetter K Cleary SH Bigner N Davidson S Baylin P Devilee (1989) ArticleTitleMutations in the p53 gene occur in diverse human tumour types Nature 342 705–708 Occurrence Handle2531845 Occurrence Handle1:CAS:528:DyaK3cXkvFyhug%3D%3D
J Varley W Brammar D Lane (1991) ArticleTitleLoss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas Oncogene 6 413–421 Occurrence Handle2011397 Occurrence Handle1:CAS:528:DyaK3MXit1alsbs%3D
R Cawthon R Weiss G Xu D Viskochil M Culver JS J Stevens M Robertson D Dunn R Gesteland P O’Connell (1990) ArticleTitleA major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations Cell 62 193–201 Occurrence Handle2114220 Occurrence Handle1:CAS:528:DyaK3cXkvFalsrs%3D
D Viskochil A Buchberg G Xu R Cawthon J STevens R Wolff M Culver JC Carey NG Copeland NA Jenkins (1990) ArticleTitleDeletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus Cell 62 187–192 Occurrence Handle1694727 Occurrence Handle1:CAS:528:DyaK3cXkvFalsro%3D
R Moll M Mitze UH Frixen W Birchmeier (1993) ArticleTitleDifferential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas Am J Pathol 143 1731–1742 Occurrence Handle8256859 Occurrence Handle1:STN:280:DyaK2c%2FnvFSmsg%3D%3D
C Gamallo J Palacios A Suarez A Pizarro P Navarro M Zuintanilla A Cano (1993) ArticleTitleCorrelation of E-cadherin expression with differentiation grade and histological type in breast carcinoma Am J Pathol 142 987–993 Occurrence Handle7682767 Occurrence Handle1:STN:280:DyaK3s3jsF2lsw%3D%3D
MR Stratton N Collins SR Lakhani JP Sloane (1995) ArticleTitleLoss of heterozygosity in ductal carcinoma in situ of the breast J Pathol 175 195–201 Occurrence Handle7738715 Occurrence Handle1:STN:280:DyaK2M3lslSnsg%3D%3D
DM Radford KL Fair NJ Phillips JH Ritter T Steinbrueck MS. Holt (1995) ArticleTitleAllelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q Cancer Res 55 3399–3405 Occurrence Handle7614479 Occurrence Handle1:CAS:528:DyaK2MXnt1antrw%3D
H Buerger R Simon K-L Schafer R Diallo R Littman C Poremba PJ Diest Particlevan B Dockhorn-Dworniczak W Bocker (2000) ArticleTitleGenetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast J Clin Pathol: Mol Pathol 53 118–121 Occurrence Handle1:STN:280:DC%2BD3czlsFGhsg%3D%3D
PP Rosen HA. Oberman (1993) Invasive carcinoma J Rosai (Eds) Tumors of the Mammary Gland AFIP Washington DC 157–257
KE Munn RA Walker JM Varley (1995) ArticleTitleFrequent alterations of chromosome 1 in ductal carcinoma in situ of the breast Oncogene 10 1653–1657 Occurrence Handle7731721 Occurrence Handle1:CAS:528:DyaK2MXlsVaqs7o%3D
D Page D Anderson L Rogers (1987) Diagnostic Histopathology of the Breast Churchill Livingston NY
RS du Toit AP Locker IO Ellis CW Elston RI Nicholson RW Blamey (1989) ArticleTitleInvasive lobular carcinomas of the breast–the prognosis of histopathological subtypes Brit J Cancer 60 IssueID4 605–609 Occurrence Handle2803932 Occurrence Handle1:STN:280:DyaK3c%2FivVSguw%3D%3D
BA Gusterson LG Machin WJ Gullick NM Gibbs TJ Powles P Price A McKinna S Harrison (1988) ArticleTitleImmunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer Int J Cancer 42 IssueID6 842–845 Occurrence Handle2903851 Occurrence Handle1:STN:280:DyaL1M%2FltlGhsA%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mohsin, S.K., O’Connell, P., Allred, D.C. et al. Biomarker profile and genetic abnormalities in lobular carcinoma in situ . Breast Cancer Res Treat 90, 249–256 (2005). https://doi.org/10.1007/s10549-004-4493-8
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-4493-8